Huntsman Corp navigates cyclical downturns with strategic focus, eyeing long-term rebound opportunities.
Huntsman Corporation is a global manufacturer of differentiated and specialty chemicals with 2024 revenues of approximately $6 billionhuntsman.com. The company operates through three primary segments – Polyurethanes, Performance Products, and Advanced Materials – serving a broad range of end markets from building insulation and automotive components to aerospace composites and consumer productsadhesivesmag.com. In the Polyurethanes segment (about 63% of 2023 sales), Huntsman is a leading supplier of MDI-based polyurethane chemicals used in rigid and flexible foams, coatings, adhesives, sealants, and elastomersen.wikipedia.org. The Performance Products segment (19% of 2023 sales) produces amines, surfactants, maleic anhydride and other chemicals used in energy, agriculture, cleaning products, coatings and as curing agentsen.wikipedia.org. The Advanced Materials segment (18% of sales) supplies high-performance epoxy and polymer resin systems (e.g. Araldite® adhesives) for infrastructure, general industry, automotive and aerospace applicationsadhesivesmag.com.
In recent years, Huntsman has streamlined its portfolio, divesting non-core businesses (such as its Textile Effects division in 2023d1io3yog0oux5.cloudfront.net) to focus on higher-margin core segments. While the company’s products are critical inputs across diverse industries and it maintains a global manufacturing footprint (60+ facilities in ~25 countries)huntsman.com, its financial performance has been cyclically sensitive. 2024 proved challenging – Huntsman reported a net loss as end-market demand softened – but management is executing cost reductions and pursuing growth initiatives in innovative materials. Overall, Huntsman’s long-term fundamentals are underpinned by its leading positions in polyurethane chemicals and specialty materials, even as near-term results reflect a downturn in the chemical cycle.
Main Revenue Drivers: Huntsman’s revenue is chiefly driven by volumes and prices in its three segments. In Polyurethanes, which contributed roughly two-thirds of 2023 revenue, sales are driven by global demand for MDI-based polyurethanes in construction, insulation, appliances, automotive interiors, furnishings, and other consumer productsen.wikipedia.org. Key drivers include housing and commercial construction (for insulation foams and building materials), automotive production (seating, composites), and general industrial activity. Polyurethanes is Huntsman’s largest division and benefits from the company’s proprietary MDI technology and systems formulations tailored to customer needs. In Performance Products (around one-fifth of revenue), drivers include industrial output and energy sector activity – this segment produces amines, surfactants, and maleic anhydride used as ingredients in agrochemicals, oil & gas additives, coatings, and personal care productsen.wikipedia.org. For example, Huntsman’s polyetheramines and ethyleneamines improve fuel performance and are used in epoxy curing agents, while its maleic anhydride is used to make unsaturated polyester resins for fiberglass and plasticsen.wikipedia.org. Advanced Materials (approximately 18% of revenue) is driven by demand for high-performance materials in aerospace, electronics, and specialty manufacturing – it supplies epoxy resins, specialty adhesives (like Araldite®), and composite materials that often replace traditional metal or wood componentsadhesivesmag.comd1io3yog0oux5.cloudfront.net. Growth in aerospace and defense, electrification (electric vehicles requiring light-weight composites and adhesives), and infrastructure upgrades all feed into advanced materials demand.
Growth Initiatives: Huntsman’s strategy emphasizes moving toward higher-margin, differentiated products and applications. The company is investing in innovation and new capacities in niche areas. Notably, Huntsman has developed an E-GRADE® product line – high-purity, low-trace metal specialty amines – to serve the semiconductor manufacturing markethuntsman.com. In May 2025, it announced a new purification and packaging facility in Texas to bolster this E-GRADE line, aiming to supply critical chemicals for chip productionhuntsman.com. This taps into a growing, high-value electronics materials market. Additionally, Huntsman is advancing its MIRALON® carbon nanotube technology, constructing a 30-ton pilot plant to convert methane into carbon nanotubes and hydrogenhuntsman.com. While still nascent, this could open opportunities in advanced materials for energy storage, composites, and emissions reduction. On the core business front, Huntsman has been upgrading and optimizing its plants – for example, completing a major multi-year turnaround at its Rotterdam MDI facility in early 2025 to improve efficiencyd1io3yog0oux5.cloudfront.netd1io3yog0oux5.cloudfront.net. The company is also implementing cost reduction programs (including workforce reductions and site rationalizations) to improve competitiveness during the downturnhuntsman.com. These initiatives, along with consistent investment in high-return internal projects (such as new polyurethane catalyst capacity and energy-saving product innovations)d1io3yog0oux5.cloudfront.net, position Huntsman to capture outsized earnings growth when demand recovers.
Competitive Advantages: Huntsman’s competitive strengths include its scale and global reach in polyurethanes – it is one of the top MDI producers worldwide, with integrated manufacturing and a presence in the Americas, Europe, and Asia. This global network enables it to supply multinational customers reliably and balance regional demand swings. The company has a broad portfolio of formulations and systems expertise, allowing it to offer customers tailored polyurethane and epoxy systems rather than just base chemicalsd1io3yog0oux5.cloudfront.net. This differentiation can foster customer loyalty and somewhat higher margins. Huntsman also owns well-known brands in specialty chemicals (e.g. the Araldite® adhesives brand in Advanced Materialsadhesivesmag.com) that carry a reputation for quality in demanding applications. Over the past decade, Huntsman has actively managed its portfolio – divesting commodity or low-growth businesses (such as its former pigments business Venator and Textile Effects) – which has sharpened its focus on divisions where it holds leading market positions and technology. This portfolio focus, combined with a culture of innovation (15+ chemical process technologies in-house and thousands of productsd1io3yog0oux5.cloudfront.netadhesivesmag.com), helps Huntsman compete on more than just price. Finally, the company’s vertical integration and feedstock advantages in some value chains provide cost efficiency. For instance, Huntsman manufactures its own amines and intermediates used in downstream products, and it has long-term JV relationships (like a PO/MTBE joint venture in China) that secure raw material supplyd1io3yog0oux5.cloudfront.netd1io3yog0oux5.cloudfront.net. These factors, along with a relatively strong balance sheet (investment-grade rated) and ongoing cost discipline, give Huntsman resilience and the ability to invest through cycles.
Nonetheless, it’s important to note that Huntsman operates in highly competitive markets. In polyurethanes, it faces large competitors (such as Covestro, BASF, and Wanhua) and competition is often based on price when industry capacity is underutilized. Huntsman’s ability to maintain an edge relies on its technical service, application development for customers, and optimizing its product mix toward specialties. The company’s broad end-market exposure can be a double-edged sword: it provides diversification, but also means Huntsman’s fortunes rise and fall with general industrial and consumer economic trends.
Recent Financial Performance (2024–2025): Huntsman’s financial results have reflected the downturn in the chemical cycle. Revenues in 2024 were $6.04 billion, essentially flat to the prior year ($6.11B in 2023) amid lower volumes and prices in key segmentshuntsman.com. The company swung to a net loss of $189 million in 2024 (GAAP), from a net profit of $101 million in 2023huntsman.com. Diluted EPS was –$1.10 for 2024 vs +$0.57 in 2023huntsman.com. Even on an adjusted basis (excluding one-time items), 2024 results were roughly breakeven – adjusted net loss of $13 million vs adjusted net income $67 million the prior yearhuntsman.com. EBITDA margins contracted significantly. Adjusted EBITDA for 2024 was $414 million (about a 6.9% EBITDA margin), down from $472 million (7.7% margin) in 2023huntsman.com. Profitability was hurt by a combination of softer demand, lower selling prices (particularly for polyurethanes due to industry oversupply and weaker construction demand), and higher energy and feedstock costs in the first half of 2024. The Performance Products segment saw notable revenue declines in 2024 due to lower commodity prices and volume, while Advanced Materials was a relative bright spot with resilient demand in aerospace and adhesives contributing to year-over-year revenue growth in Q4 2024prnewswire.com. Huntsman did manage to generate free cash flow (FCF) of $101 million in 2024, a sharp improvement from just $21 million in 2023huntsman.com. This FCF uptick came mainly from working capital release and reduced capital expenditures, even as earnings were weak.
Early 2025 results show continued headwinds. Q1 2025 revenue was $1.41 billion, down 4% year-on-yearhuntsman.com, and Huntsman posted a small net loss of $5 million for the quarter (–$0.03 per share)huntsman.com. Adjusted EBITDA in Q1 2025 was $72 million, a 11% decline from $81 million in Q1 2024huntsman.com, with softness noted in construction, transportation, and other industrial markets. The company has pointed to “low visibility and customer uncertainty” in early 2025, as cautious customers reduced orders in anticipation of potential economic weaknesshuntsman.com. Notably, Huntsman’s normally stronger Q2 seasonal pickup was described as muted so far, prompting management to remain aggressive on cost controlhuntsman.com. On the positive side, the Q1 2025 net loss was much narrower than the year-ago loss (a $5M loss vs $37M in Q1 2024)huntsman.com, indicating that Huntsman’s cost-cutting and efficiency efforts are yielding some benefit, even amid lower sales. The company’s operating cash flow was negative $71 million in Q1 (typical due to seasonal build of working capital)huntsman.com, and it continues to return cash to shareholders via its dividend. In summary, Huntsman’s recent performance (2024 into early 2025) has been under pressure from the macroeconomic slowdown and chemical down-cycle, resulting in compressed margins and near-breakeven earnings. However, the company remains cash-flow positive on a trailing basis and has taken steps to right-size its cost base for the environment.
Key Balance Sheet Metrics: Huntsman entered 2025 with a solid balance sheet relative to its size. As of March 31, 2025, total debt was $1.95 billion, offset by $334 million of cashhuntsman.comhuntsman.com, for net debt around $1.62 billion. The debt-to-equity ratio is moderate at ~0.74stockanalysis.com, and the company retains an investment grade credit rating (recently BBB–, though just downgraded one notch in April 2025 with a stable outlook). Book value stood at roughly $3.17 billion in Q1 2025, equating to a book value per share of ~$17–18. Huntsman’s leverage has ticked up in the downturn (net debt/EBITDA is elevated due to the earnings trough), but overall debt levels remain reasonable and liquidity is ample (the company also has undrawn credit facilities). Importantly, Huntsman’s free cash flow generation is expected to improve if earnings recover, as maintenance capital expenditures are relatively low (~$200M/year)fitchratings.com and working capital can release cash when sales slow (as seen in 2024). This financial flexibility allowed Huntsman to continue its quarterly dividend of $0.25 per share (raised in 2022) even during the 2024 slumphuntsman.com. The dividend, which sums to $1.00 annually, currently yields an attractive ~8% at the recent stock price – though this high yield also reflects market caution about the earnings outlook.
Valuation Multiples: Huntsman’s stock has sold off sharply over the past 18 months, resulting in seemingly low valuation multiples on some measures – but elevated on others due to depressed earnings. At a share price of around $12 (May 2025), Huntsman trades at a price-to-book ratio of ~0.7×, meaning the stock is valued at only ~70% of its accounting book valuestockanalysis.com. This signals a significant discount, as chemical sector peers often trade around 1× book (for instance, Eastman Chemical’s P/B is about 1.0× to 1.6× depending on recent market prices)companiesmarketcap.com. The stock’s price-to-sales ratio is only ~0.35× stockanalysis.com, reflecting very low market capitalization relative to its $6B revenue base – a level well below the sector average P/S of ~1× for specialty chemicals, indicating investors are pricing in weak margins. Traditional earnings multiples are less meaningful at the moment: trailing P/E is not applicable (negative earnings), and even on a forward basis P/E is unclear because 2025 consensus EPS is low (analysts currently predict only a modest profit, making forward P/E in the high teens or not meaningful).
Enterprise value metrics provide insight into the depressed EBITDA. Huntsman’s current EV/EBITDA is around 10.9× (trailing)stockanalysis.com, which is higher than many peers – for example, Eastman Chemical (a comparable specialty chemicals firm) recently traded at ~6–7× EV/EBITDAin.investing.com. This elevated EV/EBITDA for HUN is a function of its cyclical trough in EBITDA; if earnings normalize higher in a recovery, the multiple would compress. For context, during stronger periods Huntsman’s EV/EBITDA has been in the mid-single digits (its 5-year low multiple was ~4.8× in late 2022 when EBITDA was temporarily strong)finbox.com. The price/free cash flow (P/FCF) multiple is currently about 27× on a trailing basisstockanalysis.com, equating to a FCF yield of ~3.6%, but this is skewed by the weak 2024 cash flow. On a more normalized cash flow (say ~$300M/year, which Huntsman achieved in better years), the forward FCF yield would be closer to 10–15%.
In terms of peer comparison, Huntsman’s valuation sends mixed signals. The stock looks cheap on asset-based and revenue-based metrics (P/B, P/S) relative to the sector, suggesting the market is assigning a low value to its equity (possibly even below liquidation or replacement value). This often happens for cyclical companies near the bottom of a cycle, when profitability is temporarily poor. At the same time, earnings-based multiples like EV/EBITDA and P/E appear high relative to peers because Huntsman’s current earnings are depressed – the market may be implicitly looking past the trough, anticipating a rebound. If one believes EBITDA will mean-revert upward in coming years, Huntsman’s forward EV/EBITDA would drop into the single digits, making it undervalued versus peers. It is worth noting that Huntsman’s dividend yield is about 8–9%, far above the chemical sector average of ~3–4%, which reflects both the stock’s price decline and management’s commitment to return cash. This high yield could indicate a value opportunity if the dividend is sustainable; however, it also suggests the market has doubts (pricing in risk of a cut or lack of growth).
Overall, HUN’s current valuation appears to price in a lot of bad news – the stock trades below book value and at a fraction of sales, indicating skepticism about future returns. In a normalized scenario (mid-cycle margins), the stock would look inexpensive, but investors are waiting for clearer signs of demand recovery or successful strategic execution before rerating the shares. The company’s financial health (moderate debt, positive cash flow) provides a cushion, but sustained improvement in EBITDA and EPS will be needed to unlock a higher valuation multiple. At present, Huntsman offers a classic cyclical value profile: low price relative to fundamentals, but requiring patience for the earnings to rebound.
Investing in Huntsman entails several major risks, largely tied to the cyclical and commodity-influenced nature of the chemicals industry, as well as macroeconomic factors:
Cyclicality of End Markets: A core risk is Huntsman’s exposure to economic cycles. Many of its key end markets – construction, automotive, electronics, furniture, textiles – are cyclical and sensitive to global economic conditions. In a downturn or recession, demand for Huntsman’s chemicals can drop significantly as customers destock and cut production. This cyclicality was evident in 2023–2024 when a post-pandemic slowdown in construction and industrial activity led to lower volumes and pricing for Huntsman. A further global macro slowdown (or a hard landing due to high interest rates) could prolong the weak demand environment, pressuring Huntsman’s sales and margins. The company has noted “low visibility” and customer caution in ordering as a current issuehuntsman.com, highlighting the difficulty of forecasting in a volatile economy. Should a recession occur, Huntsman’s revenues could decline and it might experience operating losses similar to past troughs.
Commodity Price and Margin Volatility: Huntsman’s earnings are affected by raw material costs and product pricing, which can be quite volatile. The company’s polyurethane business relies on petrochemical feedstocks like benzene, propylene, and methanol – prices for which fluctuate with oil/gas markets. Rapid increases in feedstock or energy costs (such as Europe’s energy spike in 2022) can squeeze Huntsman’s margins if it cannot pass through costs immediately. At the same time, the selling prices of Huntsman’s own products (e.g. MDI, epoxy resins, surfactants) are influenced by global supply-demand balances. When industry capacity is underutilized, product prices can fall sharply. For example, MDI prices have been under pressure due to new capacity in China and softer demand, which hurt Polyurethanes margins in 2024. This commodity-like pricing risk means Huntsman’s profitability can swing widely. Prolonged oversupply in any major product line (perhaps from competitors expanding capacity) could keep prices and margins depressed. The company does use hedging for some raw materials and has formula pricing with certain customers, but it cannot fully escape commodity volatility.
Exposure to China and Global Trade: Huntsman generates a significant portion of sales in Asia (particularly China) and Europe (roughly 38% and 24% of 2023 sales, respectively)d1io3yog0oux5.cloudfront.netd1io3yog0oux5.cloudfront.net. A slowdown in China’s economy is a notable risk, as China is a huge consumer of polyurethane foam (for appliances, construction, footwear) and other chemicals. Currently, China’s economic recovery has been uneven; weakness in Chinese construction and consumer goods demand has reduced Huntsman’s volume growth in Asia. Additionally, geopolitical and trade factors pose risk: tariffs or trade barriers (like the ongoing US-China trade tensions) can disrupt supply chains. In fact, Huntsman’s CEO remarked that uncertainty around tariffs impacted orders in key markets in early 2025huntsman.com. The company also operates a joint venture in China; heightened geopolitical conflict or decoupling could impair its local operations or market access. On the flip side, China has significant domestic competitors (e.g. Wanhua in MDI) – their aggressive expansion can flood the market and erode pricing globally, a dynamic Huntsman cannot control.
Industrial Operations and Environmental Risks: As a chemicals manufacturer, Huntsman faces operational risks such as plant outages, accidents, or environmental incidents. Unplanned production disruptions (due to fires, explosions, hurricanes, etc.) could result in lost sales and significant repair costshuntsman.com. The company also must continuously comply with environmental and safety regulations in multiple jurisdictions; any violations or need to make costly upgrades (for example, to meet new EU environmental rules) could impact financial performance. Furthermore, longer-term sustainability trends – while not an immediate ESG focus of this report – still pose a strategic risk: for instance, if polyurethane foam or certain amines face regulatory restrictions for health/environmental reasons, Huntsman would need to adapt its product lines. The company’s 2023 sustainability report indicates awareness of these issues, but they remain potential risk factors.
Foreign Exchange and Inflation: Huntsman’s global operations mean that currency fluctuations (USD vs EUR, CNY, etc.) can affect results. A strong U.S. dollar can reduce the translated value of overseas sales and make U.S.-produced exports less competitive. Inflation, particularly in manufacturing inputs, is another factor – while raw material inflation can sometimes be passed through, general cost inflation (wages, utilities) could pressure margins if not offset by pricing. In 2024, inflation in energy and logistics costs hurt European operations. Persistent inflation might also drive up interest rates further, indirectly dampening end-market demand (e.g. housing).
Financial and Capital Allocation Risks: While Huntsman’s balance sheet is in decent shape, extended periods of low earnings could stress its financial metrics. If EBITDA stays weak, leverage ratios will remain elevated and could eventually threaten the company’s investment-grade credit rating or raise borrowing costs. Additionally, Huntsman’s generous dividend costs about $172 million per year (at $1.00/share and ~172M shares). If cash flows don’t improve, the dividend’s sustainability could come into question – a cut, while perhaps prudent to conserve cash, could trigger a negative market reaction given the stock’s income appeal. The company paused share repurchases in 2023–2024 due to low free cash flowfitchratings.comfitchratings.com; in a prolonged downturn investors shouldn’t count on buybacks or dividend growth, and indeed a dividend reduction is a risk in a severe scenario.
Macroeconomic Trends: Broadly, Huntsman is a proxy for industrial economic health. High interest rates (to combat inflation) have already cooled construction and manufacturing activity – a continued regime of higher rates could suppress Huntsman’s end-market growth. Conversely, any unexpected surge in energy prices (due to geopolitical events) could squeeze the cost side. On the other hand, there are macro factors that could mitigate risks: for example, government infrastructure spending initiatives or energy-efficiency regulations (insulation, EV adoption) could stimulate demand for Huntsman’s products in the medium term. The timing and impact of such positives are uncertain. For now, the macro outlook is mixed: many economists foresee sluggish growth in 2025 with potential recession in the US or Europe, which tempers expectations for a quick rebound in chemical demand.
In summary, Huntsman’s risk profile is characterized by high cyclical exposure and operational leverage to the broader economy. The company itself acknowledges that “significant risks and uncertainties may relate to volatile global economic conditions, cyclical and volatile product markets… and other financial, economic, competitive factors.”huntsman.com. Investors must be prepared for earnings volatility. Mitigants include management’s proactive cost-cutting (to improve break-even points), the company’s diversification across products and geographies (no single customer or end market dominates), and a relatively strong liquidity position to weather storms. Nonetheless, in a bearish macro scenario, Huntsman could face further profit pressure, while in a recovery scenario it has substantial operating leverage to the upside. This duality makes risk management and careful monitoring of economic indicators key for any investment thesis in HUN.
We evaluate Huntsman’s potential 5-year total return under three scenarios – High, Base, and Low – to gauge the range of outcomes by 2030. Total return will derive from share price appreciation/depreciation plus dividends received. Huntsman’s current share price around ~$12 provides a low starting point, so future returns could be significant if fundamentals improve (but also limited downside cushioning if things go wrong). Below we outline each scenario with its key assumptions, likely fundamentals, and projected 5-year share price. A summary table of the projected share prices is provided, followed by probability-weighted analysis. (Note: Dividends are considered qualitatively in returns, assuming the current $1.00/year is maintained in Base/Bull cases and cut in Bear case.)
High (Bull) Case – “Cyclical Upswing”: In this optimistic scenario, global economic growth resumes robustly in 2025–2026 (avoiding recession), leading to a strong upcycle in Huntsman’s end markets. Demand for MDI and other polyurethanes accelerates, aided by a recovery in construction (perhaps driven by government infrastructure spending and pent-up housing demand) and continued growth in automotive and appliance production. At the same time, industry supply tightens – for instance, no major new MDI capacity beyond what’s already online, and Chinese producers exhibit supply discipline. This allows polyurethane margins to recover to mid-cycle levels or better. We assume by 2027–2028, Huntsman’s Polyurethanes segment EBITDA per ton is markedly higher than in 2024, approaching the levels seen during the 2021 boom. The Performance Products segment also benefits from industrial recovery and higher oilfield activity (boosting amine volumes), while Advanced Materials grows nicely with aerospace and EV demand. In this bull case, Huntsman’s cost-cutting pays off exactly when revenues rebound, yielding significant operating leverage. We envision EBITDA expanding to perhaps ~$800 million or more by 2027 (nearly double 2024’s level), and adjusted EPS climbing into the ~$2.00–$3.00 range. The company likely continues its $0.25 quarterly dividend and could even increase it modestly or resume share buybacks as cash flow surges (in the late 2020s). Also, strategic moves add value: Huntsman might successfully sell a non-core business (e.g. its European maleic anhydride unit) at a good price in 2025, bringing in cash and improving focushuntsman.com. With stronger earnings and a more streamlined portfolio, the market re-rates HUN’s valuation. In a bull scenario, we assume the stock’s P/E expands to ~12× and EV/EBITDA to ~7× (still conservative relative to peaks, reflecting the company’s cyclical nature). If EPS were ~$2.50 by 2030, a 12× multiple yields a stock price of $30. Alternatively, at an EBITDA of $800M and EV/EBITDA 7×, enterprise value would be $5.6B; subtracting ~$1.5B net debt gives equity value ~$4.1B, which over ~170M shares also implies ~$24 per share. We weight the higher P/E method since bull markets often grant higher multiples – plus Huntsman might reduce share count with buybacks. Thus, our High case share price target is approximately $30 in five years. Including about $5+ in cumulative dividends over that period, the total return could approach ~190% (nearly triple the current price). This scenario assumes smooth execution and a favorable macro environment – essentially a return to Huntsman’s prior peak earnings with some incremental strategic wins.
Base Case – “Gradual Recovery”: In the base case, the next five years see moderate improvement in fundamentals. Perhaps the global economy experiences a shallow downturn in 2025 but then returns to trend growth. Huntsman’s end markets recover gradually: housing and construction stabilize by 2026 (neither a boom nor a bust), automotive builds improve with the EV transition (benefiting both polyurethanes and advanced materials), and industrial demand slowly picks up. Importantly, supply gluts in key products ease – e.g., Chinese MDI overcapacity is absorbed by rising domestic demand or rationalization. Huntsman, under the continued leadership of CEO Peter Huntsman, executes on its cost optimization plans, achieving the targeted savings (through workforce reductions and site consolidations). The company’s growth projects begin contributing: the new Miralon carbon nanotube plant finds niche applications, and E-GRADE amines win contracts with chip manufacturers, adding a small but growing revenue stream. We assume Huntsman’s EBITDA margin improves back into the low double-digits (say 10–12%) from the 7% in 2024. By 2030, EBITDA might reach ~$600–650 million, and annual EPS could be on the order of $1.00–$1.50 (assuming interest expense roughly stable and a normalized tax rate). In this base scenario, Huntsman is a financially healthier company: free cash flow consistently positive ($200M+ per year), allowing it to comfortably maintain the $1.00 dividend (total of ~$5 paid over 5 years) and possibly reinstate modest share repurchases if cash flow exceeds capex+dividends. However, growth is not spectacular – this is a steady climb out of the trough rather than a sharp surge. The market, accordingly, values HUN at a somewhat subdued multiple given the company’s middling growth and still-cyclical profile. We assume a P/E of ~10× on 2030 earnings in this case, or EV/EBITDA ~8×. If EPS in 5 years is around $1.20, a 10× multiple yields a stock price of ~$12 (which, notably, is around the current price; however, one would also have collected dividends for a positive total return). We think earnings will be a bit higher by then, so let’s consider EBITDA-based: at $600M EBITDA and 8× multiple, EV would be $4.8B; subtracting ~$1.4B net debt (assuming some debt paydown) leaves equity ~$3.4B, or roughly $20 per share. Balancing these methods, our Base case 5-year share price is around $18–20. We will use $20 as the target, as it aligns with the midpoint and also roughly with Huntsman’s book value (which could still be in the high teens per share by then). Total return in this scenario would be solid: starting at $12, rising to $20, plus ~$5 of dividends = ~$25 total value, about a +108% cumulative return (~15.8% CAGR). This assumes no dividend cuts and a moderate valuation recovery as the company returns to consistent profitability.
Low (Bear) Case – “Prolonged Slump”: In a pessimistic scenario, Huntsman faces persistent challenges and a lackluster recovery. Perhaps the global economy falls into a recession in 2025, with only a tepid rebound thereafter. Under this scenario, key end markets remain soft: construction activity languishes (high interest rates and slow housing starts), manufacturing PMIs stay weak, and China’s growth continues to disappoint. In addition, industry headwinds could intensify – for example, competitors keep adding capacity (new Asian plants for MDI or epoxy resins), leading to chronic oversupply and downward pricing pressure. Huntsman’s efforts to cut costs help but cannot fully offset the external pressures. The company might struggle to get EBITDA much above the ~$400M level for years, and pricing power remains limited. We might see continued earnings volatility: some quarters of small profits, others of small losses, but generally low margins (single-digit percent). In this scenario, Huntsman might be forced to make tougher choices, such as temporarily cutting its dividend to conserve cash. The dividend could be reduced, say by 50%, if free cash flow stays weak – an action that would likely hurt the stock in the short term but preserve capital. Capex might also be trimmed further, risking underinvestment. While Huntsman likely would avoid major financial distress (thanks to its reasonable debt load), the equity could remain “out of favor” for an extended period. In this bear case, assume by 2030 EPS is still only around $0.50–$0.70 (or worse, break-even), and the market assigns a low multiple given uncertain prospects – maybe 8× earnings. That would yield a stock price in the mid-single digits (0.6 * $0.50 = $4 at the low end). However, even in a bearish case, completely discounting Huntsman’s asset value seems unlikely; the stock might find support from its tangible book value or private equity interest if it dropped too far. Let’s assume the stock in a bad scenario drifts down to around $8–10 per share (near or below the previous cycle low). $10 would equate to roughly 0.5× book and reflect continued poor ROE. We’ll take $10 as the Low case price outcome. In terms of total return, it would be weak: if the dividend is cut, perhaps only ~$2–3 of dividends are received over 5 years. So an investor starting at $12 might end up with ~$10 + dividends = ~$13 total value, which is only ~8% above today’s price (essentially flat, ~1–2% annualized return, and potentially a loss in real terms). The risk of further downside below $10 exists if, for example, a major crisis hit (the stock traded in the single digits in 2008–09 and again briefly in 2016 when conditions were diremacrotrends.net), but we consider $8–10 a likely floor barring a truly severe collapse in the business.
Below is a table summarizing the estimated share price outcomes under each scenario by 2030:
| Scenario | Projected 5-Year Share Price |
|---|---|
| High (Bull) – Cyclical Upswing | $30 |
| Base – Gradual Recovery | $20 |
| Low (Bear) – Prolonged Slump | $10 |
(Note: Prices are in nominal dollars for 2030. Total returns would include dividends on top of these prices.)
Probability-Weighted Outcome: Assigning subjective probabilities to each scenario can help form a weighted expected value. Given the current environment and Huntsman’s historical tendencies, one might assign: Base 50% probability, Bull 25%, Bear 25% (for example). Using those weights with the above targets:
Base: 50% * $20 = $10.0
Bull: 25% * $30 = $7.5
Bear: 25% * $10 = $2.5
This yields a probability-weighted price of $20.0 (which interestingly is the same as the base case in this weighting scheme). If we include an estimate of dividends (say ~$5 in base/bull, $2.5 in bear weighted accordingly), the probability-weighted total return value might be around $22–$23, implying roughly an 80–90% upside from the current $12 over five years. This suggests a favorable risk-reward skew, assuming the base case (or better) materializes with decent likelihood. Of course, if one heavily weights the bear case (e.g. believes recession is highly likely), the calculus changes.
In summary, Huntsman offers significant upside in a cyclical rebound (the bull case could see the stock doubling or more, as it has in past upswings), while the downside, though not trivial, is mitigated somewhat by the already low valuation and tangible book support. Our probability-weighted analysis leans slightly positively, reflecting an expectation of eventual cyclical recovery. The outcome is highly dependent on macro conditions and management execution, making this a “value with a catalyst” story – the catalyst being an eventual economic and chemical industry upturn.
Bold case conclusion: Moderate Upside
To qualitatively assess Huntsman, we rate the company on several key dimensions (scale of 1 to 10, with 10 being best) and provide brief commentary for each. Finally, we compute an overall blended score and summary.
Management Alignment (7/10): Management’s interests are reasonably aligned with shareholders. CEO Peter Huntsman (son of founder Jon Huntsman) and insiders own about 5–6% of the stockstockanalysis.com, which is a modest but meaningful stake. The company has a track record of returning cash to investors (regular dividends and share buybacks when feasible). Notably, an activist fund (Starboard) took an ~8% stake in 2021 to push for changesen.wikipedia.org, and while they have since exited, Huntsman did execute several portfolio improvements (selling non-core businesses) in line with shareholder value creation. This suggests management is responsive to shareholder concerns. The leadership has also refrained from empire-building M&A (a proposed 2017 merger with Clariant was called off) and instead focused on core businesses, which indicates discipline. One area to watch is executive compensation – it’s fairly typical for the industry and thus far there haven’t been red flags in terms of excessive pay. Overall, while the Huntsman family’s involvement means insiders have influence, outside shareholders’ interests seem reasonably protected, and strategic moves (like portfolio streamlining and cost cuts) have shown management’s intent to drive value.
Revenue Quality (5/10): Huntsman’s revenue quality is average, reflecting a mix of differentiated products and commodity-like exposure. On one hand, a portion of sales come from specialized formulations (e.g. advanced epoxy systems, specialty amines) that offer value-add and potentially more stable customer relationships. The Advanced Materials segment, for instance, sells into aerospace and other high-spec markets where qualification and performance matter more than price, lending some durability to revenue. On the other hand, a large chunk of Huntsman’s revenue – especially in Polyurethanes and parts of Performance Products – is cyclically driven and sensitive to commodity pricing. There is little recurring or subscription-like revenue; most sales are transactional chemical orders that can fluctuate quarter to quarter. The diversity of end markets (no single end market dominates sales) helps smooth out some volatility, but overall revenue is still tied to industrial cycles. We also note that Huntsman has limited pricing power when its products are in oversupply (as seen by falling selling prices in 2023–24). Thus, revenue quality gets a middle score: not as defensive as, say, a specialty chemical company with patented products, but not as low-quality as a pure commodity chemical firm thanks to its differentiated applications.
Market Position (7/10): Huntsman holds strong market positions in several of its businesses, though it is not the absolute leader in all. In MDI-based polyurethanes, Huntsman is among the top global players (historically in the top 3–4 producers globally), with well-known MDI brands and systems. This scale provides advantages in manufacturing efficiency and customer reach. In amines (Performance Products), Huntsman is a leading producer globally, especially in specialty amines and maleic anhydride, giving it a solid niche presencechempoint.comlinkedin.com. The Advanced Materials unit has a reputable position in epoxy resins and adhesives (Araldite is a legacy brand widely recognized in high-performance adhesivesadhesivesmag.com). However, Huntsman does face formidable competitors: for example, in polyurethanes it competes with giants like Dow, BASF, and Wanhua, some of which have larger market share and integration. In Advanced Materials, competitors like Olin (in epoxies) and Hexcel or Solvay (in composites) vie in overlapping areas. So while Huntsman is well-established and often top-tier in its chosen product lines, it isn’t a monopoly or unchallenged leader. Its market share is meaningful but not dominant enough to set industry direction unilaterally. The company’s geographic breadth (sales roughly one-third each in US, Europe, Asia)d1io3yog0oux5.cloudfront.net does enhance its market position as a global supplier. Overall, Huntsman’s positions are strong in niches (hence a relatively high score), but intense competition in chemicals prevents a higher score.
Growth Outlook (5/10): The growth outlook for Huntsman over the next 5+ years is mixed, earning a middle score. On the positive side, Huntsman has exposure to some structural growth themes: increasing insulation and energy efficiency standards (benefiting polyurethanes in construction), the transition to electric vehicles (requiring lightweight materials and adhesives from Advanced Materials), and semiconductor industry expansion (new E-GRADE chemicals targeting that)huntsman.com. These could drive above-GDP demand for certain Huntsman products. The company’s streamlined focus and innovation pipeline (e.g. carbon nanotubes) also provide avenues for incremental growth. However, offsetting this is the reality that many of Huntsman’s businesses are in mature or cyclical industries where long-term growth may only track global GDP at best. Polyurethane demand tends to grow with construction and consumer goods – which is moderate. Additionally, after the post-COVID restocking, the industry is digesting capacity; near-term growth is likely subdued until excess supply is absorbed. Analysts currently expect only modest growth for Huntsman – the consensus 2025 revenue is roughly flat to up slightly from 2024. Unless Huntsman makes a transformative acquisition or breakthrough, its organic growth will likely be in the low single digits annually, punctuated by cyclic ups and downs. Therefore, we view the medium-term growth outlook as moderate – not a secular growth story but with pockets of opportunity if management executes well.
Financial Health (6/10): Huntsman’s financial health is reasonably good. The company has a solid balance sheet with moderate leverage – debt to equity is ~0.7 and net debt/EBITDA is elevated currently (~4×) but should improve with earnings recoverystockanalysis.com. Fitch Ratings recently affirmed an investment-grade rating (BBB-), noting stable outlookfitchratings.com. Liquidity is adequate: ~$334M cash on hand and access to credit lines. Huntsman’s current ratio 1.5 indicates it can cover short-term liabilities comfortablystockanalysis.com. The interest coverage is a bit thin at the moment (due to low EBIT), but the absolute interest expense is manageable ($80M/year) relative to cash flow. The company has been prudent to pause share buybacks when cash flow fell, which preserved its capital structure. One area that detracts from a higher score is the pension and other long-term liabilities – Huntsman, like many industrials, has some underfunded pension obligations (though not alarming in size). Also, if the downturn persisted, the relatively high dividend payout could constrain financial flexibility (FCF payout was very high in 2024, effectively >100% of FCF). Still, given manageable debt levels and no near-term maturities that pose a threat, Huntsman’s finances are in decent shape to ride out a cycle. It’s not ultraconservative (hence not scoring higher), but it isn’t overly risky either.
Business Viability (8/10): We assess Huntsman’s long-term business viability as strong. The company is in the business of providing essential chemical materials that are unlikely to become obsolete in the foreseeable future. Polyurethanes, epoxies, and performance additives are deeply embedded in modern life – from insulation foam that improves energy efficiency to composites that lighten vehicles to adhesives that enable advanced manufacturing. The sheer breadth of applications provides confidence that Huntsman’s core products will remain in demand. Huntsman also has shown adaptability: when certain lines (like textile dyes or titanium dioxide pigments) became less viable for them, they exited those to focus on more competitive areas. This suggests the business as a whole can evolve. Barring a revolutionary materials science breakthrough that replaces polyurethane foam or epoxy (which seems unlikely on a large scale in the medium term), Huntsman’s business will continue. One viability consideration is environmental regulation – e.g. MDI is toxic in raw form and there could be stricter rules on its handling or on foam blowing agents. However, these are manageable through innovation (e.g. developing lower-emission products). The company’s diversified product mix also means no single technology shift can topple it. For instance, even if polyurethane usage slowed, perhaps advanced composites or other lines would pick up slack. Therefore, Huntsman’s business model and industry position appear sustainable well into the future. The high score reflects that the world will still need Huntsman’s chemistry in 5, 10, 20 years, even if cycles and product mix shift.
Capital Allocation (5/10): Huntsman’s capital allocation track record is mixed. On one hand, management has made some savvy moves: divesting low-margin businesses (the 2017 spin-off of Venator pigments, the 2023 sale of Textile Effects) to unlock value and reduce cyclicality. They have also invested in growth capex more cautiously in recent years, keeping capex around ~$200M and focusing on high-return projects (like the splitter upgrade for MDI, new specialties in Performance Products) rather than big speculative builds. Additionally, Huntsman returned a lot of cash to shareholders in the 2018–2022 period via buybacks and dividends (including a substantial accelerated share repurchase in 2021). However, there have been some capital allocation missteps historically: e.g. the acquisition of the Pigments business (which became Venator) was value-destructive as that unit struggled and eventually went bankrupt in 2023en.wikipedia.org. Timing of buybacks was not ideal – they repurchased shares near cyclical peaks and then had to halt buybacks when the stock became cheap in 2023–24 (common issue for cyclicals). The dividend policy has been consistent, but one could argue management might have been better off cutting the dividend in 2024 to preserve cash for buybacks at low prices – their decision to maintain it prioritizes income investors but could limit flexibility. Capital allocation to growth vs shareholder returns has been balanced, but the effectiveness has been average – ROIC over the cycle has been in the mid-single digits, indicating only modest value creation. With an activist on board in 2021, capital allocation improved (they avoided an M&A spree and instead sold assets and bought back stock), so recent trend is positive. We give a neutral score as Huntsman’s allocation has had both positives (portfolio pruning, conservative capex) and negatives (some past M&A, timing issues).
Analyst Sentiment (4/10): Current Wall Street sentiment on Huntsman is lukewarm to negative. Following the weak results in early 2025, many analysts cut their price targets and ratings. As of May 2025, the consensus rating is “Hold” with a skew toward cautious views: 3 analysts rate HUN a Sell, 7 Hold, and only 1 a Buymarketbeat.com. The average price target is about $15 – only slightly above the trading price – indicating limited near-term upside seen by analystsmarketbeat.com. For example, in May 2025 Morgan Stanley cut its target from $20 to $13.50, citing a pessimistic outlookmarketbeat.com, and others like Citigroup and Wells Fargo have also lowered targets into the mid-teens or belowmarketbeat.com. This negative revision trend suggests analysts are concerned about the pace of recovery and margin pressures. That said, sentiment was much more positive a year or two ago when conditions were better – so it tends to swing with the cycle. The current low score reflects that near-term sentiment is poor (which can sometimes be a contrarian positive for the stock). If Huntsman delivers a couple of quarters of improvement, we could see upgrades. But as it stands, sell-side conviction in Huntsman is lacking, and catalysts are not broadly anticipated in the immediate term.
Profitability (4/10): We rate profitability on a through-cycle basis, and Huntsman is below average right now. 2024 profitability was obviously weak – negative net margin (–3.1%) and adjusted EBITDA margin ~6.9%huntsman.com. Even in better times, Huntsman’s margins and returns have been moderate. Over the last decade, EBITDA margins have typically been in the low teens at peak, and ROIC has often been in the mid-single digits. This is partly inherent to the industry (chemicals tend to be mid-margin businesses), but Huntsman’s profitability trails some more specialty-focused peers. For instance, its 5-year average return on invested capital is likely around 5–8%, which is at or slightly below its cost of capital, implying limited economic value add. Profitability in Polyurethanes is very cycle-dependent – during 2017–2018, that segment had excellent margins when MDI was tight; but in gluts, margins evaporate. Advanced Materials has decent margins (~15% EBITDA margin in 2023) but is only ~18% of salesadhesivesmag.com. Performance Products margins are low to mid teens as well. There’s also a history of periodic charges/impairments (restructuring costs, etc.) which drag GAAP profits. On the positive side, Huntsman’s focus on cost reduction should improve baseline profitability by perhaps 200–300 basis points when fully realized. Also, the company tends not to over-invest in low-return projects, which helps avoid diluting returns. But until we see a sustained uptick in margins and ROIC, Huntsman’s profitability can only be seen as subpar relative to an ideal. The score reflects current underperformance, with the expectation that profitability can normalize upward, but still likely remains in the middle of the pack among chemical firms even then.
Track Record (5/10): Huntsman’s track record for performance and execution is mixed. Over its nearly 20-year history as a public company, it has navigated multiple cycles, nearly merged with Clariant (terminated) and settled a major lawsuit with Apollo, spun off divisions, etc. From a shareholder return perspective, the track record is so-so: The stock today (~$12) is below where it traded 5 years ago, and roughly on par with 10 years ago (aside from dividends). There have been periods of great returns – e.g., 2016 to early 2018 the stock surged (from ~$6 to ~$35) as the cycle turned and Huntsman executed an IPO of Venator and talked up transformation plans (shareholders who timed that did very well). But those gains evaporated in subsequent downturns; for instance, HUN lost ~40% in 2018macrotrends.net, and fell ~25% in 2022 and another ~25% in 2024macrotrends.net. Operationally, the company generally meets guidance in normal times, but forecasting is difficult in volatile markets (they missed some estimates in 2023–24 due to rapid market shifts). On strategic delivery: Huntsman did achieve many portfolio moves it promised (the recent divestitures, cost cuts, etc.), though some initiatives took longer than hoped. One could say management has done reasonably well controlling what it can (costs, asset mix), but external forces have often dictated results. The middling score reflects that while Huntsman has survived and adapted (no existential missteps), it also hasn’t been a consistent value creator – returns have been cyclical and an investor’s experience heavily depends on entry/exit timing. The credibility of management is decent, but investors likely view Huntsman as a show-me story at this point.
Overall Blended Score: Averaging these categories (with equal weight) yields an approximate overall score of 5.6/10, which we can consider around 6/10 in qualitative terms. This suggests that Huntsman is an “average quality” investment proposition – it has some clear strengths (market position, viable business model) but also notable weaknesses (cyclicality affecting profitability, lack of growth). It is neither a high-flying growth star nor a distressed asset, but a cyclical company that requires careful consideration of timing and execution.
Overall qualitative summary: Average Quality
Investment Thesis: Huntsman Corp presents a classic cyclical value investment case – the company is currently navigating a downturn, but has solid long-term fundamentals and could generate substantial upside when conditions improve. At ~$12 per share, HUN is trading at depressed multiples (0.7× book, ~4× mid-cycle EBITDA, ~6% forward FCF yield) that reflect recent strugglesstockanalysis.com. The core thesis is that Huntsman’s earnings power is higher than what the market is pricing in, and as the economic cycle turns up, Huntsman’s profits and valuation could mean-revert, driving the stock higher. The company’s leading positions in polyurethanes and specialty materials, combined with its streamlined portfolio and cost-cutting efforts, position it to benefit disproportionately from a rebound in demand. In the meantime, investors are paid to wait via a hefty dividend (8% yield).
Key catalysts ahead include: (1) Macro recovery or stabilization – even a modest pickup in construction, automotive, and industrial orders in late 2025 or 2026 would boost Huntsman’s volumes and pricing. There are early signs to watch, such as housing starts or PMI indices, which could foreshadow improving demand for Huntsman’s products. (2) Operational execution and cost savings – Huntsman is targeting significant cost reductions (it has announced workforce cuts and optimization of European operationshuntsman.com); successful execution here will lift the earnings baseline regardless of external factors. Progress on margins could become evident in coming quarterly results, serving as a catalyst for re-rating. (3) Portfolio actions – the company is reviewing strategic options for its European maleic anhydride business (a smaller non-core asset)huntsman.com, which could result in a sale by mid-2025. A sale would bring in cash (potentially used for debt reduction or buybacks) and show management’s continued focus on core competencies. Longer term, Huntsman could even become an acquisition target itself if its valuation stays low – larger chemical companies or private equity might see an opportunity to scoop it up (the stock’s discount to book and the family’s waning involvement could make it intriguing, though no indications of this yet). (4) New products and growth projects – wins in the semiconductor chemicals space (E-GRADE) or adoption of Miralon nanotubes by customers could provide incremental growth news, showcasing Huntsman’s innovation and opening new markets.
However, the risks and uncertainties discussed are very real. A key risk is that the anticipated cyclical upturn takes much longer to materialize or is weaker than historical norms. If high interest rates and China’s challenges persist, Huntsman might muddle through with low earnings for several years, which would test investors’ patience (and could force a dividend cut that might negatively impact the stock in the short run). Another risk is execution risk – while Huntsman has outlined cost cuts, it needs to implement them without disrupting operations or sales. Unexpected setbacks (operational outages, raw material spikes, etc.) could also derail progress. Additionally, the chemical sector often moves in sympathy; if peers issue profit warnings or the sector falls out of favor, Huntsman’s stock could languish even if it is individually on track.
From a long-term perspective, Huntsman’s risk-reward appears favorable. The downside seems limited by the company’s tangible value and diversified business (it’s hard to envision the stock going far below book value barring a deep recession). The upside, on a 3-5 year view, could be substantial if Huntsman simply returns to mid-cycle profitability – as our scenario analysis showed, a probability-weighted outcome points to decent double-digit share price with dividends on top. Thus, for investors with a contrarian bent and tolerance for cyclicality, Huntsman offers a compelling “reversion to mean” story. The stock is essentially a bet that “this too shall pass” – that the chemical cycle will turn, and Huntsman’s earnings and stock price will recover accordingly.
In conclusion, Huntsman is a potentially rewarding investment for long-term investors willing to endure short-term volatility. The company has refocused on its core strengths, maintains financial stability, and stands to benefit from any improvement in global industrial activity. One should keep an eye on macro indicators and management’s execution of cost and strategy initiatives as barometers for the thesis. Given the current discount and future prospects, the investment thesis can be summarized as cautiously optimistic: Huntsman is a “cyclical value play” where patience and timing could yield attractive returns, but near-term risks warrant caution.
Overall thesis summary: Cyclical Upside
Huntsman’s recent price action has been decidedly weak, with the stock in a persistent downtrend. Over the past year, HUN has fallen from a high in the mid-$20s to around $12 now – a drop of ~50% from its 52-week high of $25.78macrotrends.net. It made a new 52-week low near $11.15 in early May 2025macrotrends.net, reflecting the market’s reaction to poor earnings and guidance. The stock is trading well below its 200-day moving average, which is in the ~$18–19 rangemarkettamer.financhill.com. This large gap signifies a strong downtrend; in technical terms, HUN is in a bearish configuration (price below both the 50-day and 200-day MAs, which themselves have a negative crossover). In fact, a recent analysis noted the 200-day SMA around $19.18, indicating a clear sell signal from a trend-following perspectivemarkettamer.financhill.com. Shorter-term momentum indicators also show weakness – for instance, the RSI (Relative Strength Index) has been hovering in the 30s (it was ~38 recentlystockanalysis.com), which is approaching oversold territory but not yet showing a definitive bullish divergence or reversal pattern.
Support and Resistance: The stock appears to have some support around the $11–$12 area, which coincides with the recent low and is near the pandemic-crash low of ~$10.8 from March 2020macrotrends.net. If the $11 level were to break decisively on high volume, the next support might be psychological around $10, then potentially the mid-single digits (the stock hit ~$6 in early 2016’s chemical downturn)macrotrends.net. On the upside, initial resistance would be around $15 (approximately the 50-day moving average and a level that was support in late 2024, now turned resistance). Above that, the $18 level (the 200-day MA and a price congestion zone from Q3 2024) is a significant resistance – it would likely take notably good news to push the stock back above that. The long-term chart shows that the stock peaked near $36 in early 2022macrotrends.net, and it has been making lower highs and lower lows since, which defines a downtrend.
Recent News & Short-Term Drivers: In the short term, news flow has been negative, which aligns with the downward pressure. Q1 2025 earnings came in below revenue expectations and management struck a cautious tonehuntsman.com. Several sell-side analysts downgraded the stock or cut price targets in April-May 2025 (e.g. multiple firms moving targets to the low-teens and issuing Hold/Sell ratingsmarketbeat.com). This spate of downgrades has likely contributed to selling momentum. Additionally, macro data (e.g. U.S. housing starts, PMI indices) in recent months have been lackluster, reinforcing the narrative of weak demand for Huntsman’s products. There was also the Fitch downgrade of Huntsman’s credit rating in April (to BBB-), which, while not a disaster, added to negative sentiment. On the positive side, there have been a few bits of good news – Huntsman increased its dividend in Q1 (which was a confidence signal) and has made announcements about new product capabilities (E-GRADE in semiconductors)huntsman.com. However, these have not been enough to overcome the broader pessimism. It’s worth noting that the stock saw a brief bounce in late 2024 when results weren’t as bad as feared, but that rally failed around $25 and reversed.
Technical Outlook: In the immediate term, the trend remains bearish until proven otherwise. The stock is below key moving averages, and any rallies have been sold. Traders likely view HUN as oversold but lacking a catalyst – it could bounce on any hints of macro improvement or if commodity prices (like benzene or polyurethanes) show an uptick. The momentum indicators (like RSI) suggest the stock isn’t extremely oversold, so there may be room for additional downside probing, especially if the overall market turns risk-off. The volume on down days has been higher than on up days, indicating distribution. For a trend reversal, one would look for a higher low to form (perhaps the stock retesting $11 and holding above it) and a break above a recent high (for instance, if HUN can climb over $14–$15 on strong volume, that might signal a bottoming). Until that happens, the path of least resistance is sideways to down.
Short-Term Forecast: Over the next few months, absent a major change in fundamentals, HUN is likely to trade in a range or drift modestly downward. The high dividend yield might provide some support, as yield-focused investors could step in if it drops too far below $12. But conversely, any significant deterioration in economic data or a miss in Q2 2025 earnings could push it below $11 briefly. Seasonally, Q2 and Q3 are usually better for chemicals, so it’s possible the stock stabilizes into the summer if results show seasonal improvement (even if muted). On balance, sentiment will need to turn for a sustained rally – perhaps from clearer evidence that the demand trough is passing. Until then, caution is warranted. Technical traders likely see any approach toward $15 as an area to lighten positions unless accompanied by bullish news. Investors might accumulate gradually at these lows, but there’s no technical confirmation of a bottom yet.
In summary, the short-term outlook for HUN remains guarded. The stock is in a downtrend below its long-term average, reflecting a market that is bracing for weak results in the near term. While valuation is cheap, technical signals have not flashed a buy reversal yet. A prudent short-term stance would be to remain cautious or neutral and watch for improvement in trend indicators before turning bullish on the stock’s price action.
Technical trend summary: Bearish Trend
View Huntsman Corp (HUN) stock page
Loading the interactive version of this report…